期刊文献+

冠状动脉再血管化治疗预后与2型糖尿病控制程度的相关性研究

下载PDF
导出
摘要 目的探讨冠心病合并2型糖尿病患者行冠状动脉再血管化治疗预后与血糖控制程度的相关性。方法 126例冠心病合并2型糖尿病患者,根据患者情况行冠状动脉旁路移植术(CABG)或经皮冠状动脉介入术(PCI)治疗,且术后均给予血糖干预,随访6个月后根据患者糖化血红蛋白(Hb A1c)水平将其分为A组(血糖控制良好)47例和B组(血糖控制不良)79例。观察比较两组患者的不良心血管事件(MACE)发生情况,并采用Logistic回归分析血糖控制程度与再血管化治疗预后的关系。结果 A组和B组的MACE总发生率分别为6.38%和22.78%,两组比较差异有统计学意义(P<0.05);回归分析结果显示,血糖控制不良是MACE发生的危险因素。结论血糖控制程度与再血管化治疗预后高度相关,可有效控制血糖水平,对于冠心病合并2型糖尿病患者的治疗和预后具有非常重要的临床价值。
出处 《中国实用医药》 2016年第12期59-60,共2页 China Practical Medicine
  • 相关文献

参考文献3

二级参考文献14

  • 1中国心脏调查组,胡大一,潘长玉.中国住院冠心病患者糖代谢异常研究——中国心脏调查[J].中华内分泌代谢杂志,2006,22(1):7-10. 被引量:470
  • 2王成岩,吕海良.浅谈对糖尿病伴冠状动脉粥样硬化性心脏病患者的预后[J].齐齐哈尔医学院学报,2006,27(5):543-544. 被引量:2
  • 3Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease [J]. Eurolntervention, 2005, 1(2): 219-227.
  • 4Pradhan AD, Ridker PM. Do atherosclerosis and type 2 diabetes share a common inflammatory basis [J]? Eur Heart J, 2002, 23(11): 831-834.
  • 5Ali Raza J, Movahed A. Current concepts of cardiovascular diseases n diabetes mellitus [J]. Int J Cardiol, 2003, 89(2-3): 123-134.
  • 6Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary-ar- tery bypass surgery and stenting for the treatment of multivessel dis- ease [J]. N Engl J Med, 2001, 344(15): 1117-1124.
  • 7Niles NW, McGrath PD, Malenka D, et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group [J]. J Am Coll Cardiol, 2001, 37(4): 1008-1015.
  • 8Stenestrand U, James SK, Lindback J, et al. Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes melli- tus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) [J]. Eur Heart J, 2010, 31(2): 177-186.
  • 9Serruys PW, Ong AT, Moriee MC, et al. Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions [J]. Eu- rolntervention, 2005, 1(2): 147-156.
  • 10Barsness GW, Gersh BJ, Brooks MM, et al. Rationale for the revas- cularization arm of the Bypass Angioplasty Revascularization Inves- tigation 2 Diabetes (BARI 2D) Trial [J]. Am J Cardiol, 2006, 97 (12A): 31G-40G.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部